Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac diethylamine 2.32% gel twice vs three times daily vs placebo in acute ankle sprain
2009-011571-71Phase 3Completed
- Sponsor
- Novartis
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of diclofenac diethylammonium in Ankle sprain (3 arms), sponsored by Novartis. Primary endpoint: Pain on movement after 5 days of treatment. Started Apr 2009; status: completed.
02
Drugs
diclofenac diethylammonium
03
Conditions
Ankle sprain
Beyond the preview
Go deeper on 2009-011571-71.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011571-71.